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Abstract
p63 is a transcription factor required for the development and maintenance of ectodermal tissues in general, and skin
keratinocytes in particular. The identification of its target genes is fundamental for understanding the complex network of
gene regulation governing the development of epithelia. We report a list of almost 1000 targets derived from ChIP on chip
analysis on two platforms; all genes analyzed changed in expression during differentiation of human keratinocytes.
Functional annotation highlighted unexpected GO terms enrichments and confirmed that genes involved in transcriptional
regulation are the most significant. A detailed analysis of these transcriptional regulators in condition of perturbed p63
levels confirmed the role of p63 in the regulatory network. Rather than a rigid master-slave hierarchical model, our data
indicate that p63 connects different hubs involved in the multiple specific functions of the skin.
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Introduction
p63 is a transcription factor homologous to p53 and p73 [1]
which binds DNA in a sequence-specific way. p63 has two
different transcription initiation sites generating proteins contain-
ing (TA) or lacking (DN) an activation domain. The 39 end of the
gene is involved in alternative splicing of three isoforms termed a,
b and c. Hence, a minimum of six p63 isoforms are present in
cells, at various levels of relative expression. Unlike p53, p63 and
p73 are not ubiquitously expressed, and are involved in
developmental processes. In particular, compelling genetic evi-
dence in mouse [2,3], human [4] and zebrafish [5,6] indicates that
p63 plays a central role in development of ectodermal tissues. It is
clear therefore, that p63 is a master regulatory gene of multi-
layered epithelia in general, and of keratinocytes in particular [7].
Identification of targets is crucial in order to understand the
developmental strategy sustained by p63. Several approaches have
been taken over the last few years, notably expression profiles of
p63 overexpressing or p63 silenced cells [8] and genome wide p63
ChIP on chip analysis [9,10]. Most of these studies provided good
evidences that p63 governs specific programs involved in epithelial
differentiation such as adhesion [11] or cancer progression [12].
We undertook a ChIP on chip screening with the human
keratinocyte cell line HaCaT, which predominantly expresses
the DNp63a isoform and identified 186 high confidence p63
targets, which were validated in different biological assays [10].
We reanalyzed these binding data with less stringent criteria and
extended the list of targets to over 1000 and confirm the pivotal
role of p63 in transcriptional regulation. An extensive validation of
targets involved in transcription in different conditions of p63
perturbation and cross reference with other public available data,
highlighted a transcriptional network in which p63 acts in
combination with its targets to drive and control specification
and development of multilayered epithelia.
Results and Discussion
The new p63 targets
In our previously published list of 186 p63 targets the percentage
of validation was almost complete, suggesting that additional
relevant targets were below the stringent threshold. We reanalysed
our data with new criteria and extendedthe list of putative targetsto
1259 gene ID: 701 from the CpG island and 579 from the promoter
arrays: 21 locations were in common. This low overlap between the
two platforms was already observed [10] and reflects the substantial
differences of the clones spotted on the two arrays. The complete list
of the gene ID is in Table S1, together with genomic coordinates of
both the positive CpG island clones and the promoter regions (see
materials and methods for additional mapping information).
Independent ChIPs from HaCaT cells with two different p63
antibodies, both recognising all p63 isoforms, performed on 40
randomly selected loci from this list, indicated in vivo binding on 25
(data not shown). This lower validation rate was expected for two
reasons: (i) the lower stringency could enhance the noise; (ii) we only
used one amplicon per locus, thus probably missing nearby p63
binding sites. A comparison with a genome wide p63 location
analysis with a non keratinocyte cell line [9] showed that 188 loci -
14.8%- are common, supporting the validity of our list. Therefore,
we considered the new list worth of further analysis.
We performed a functional classification through the WebGes-
talt Gene Set Analysis Toolkit, which allows handling of a large
number of genes and performs statistical enrichment of GO terms
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e5008[13]. The results are visualized as a tree shown in Figure S1 and a
more simplified version is in Figure 1. The two major statistically
enriched categories were development (141 genes) and transcription
(179 genes) (Figure 1). These two classes emerged also from our
previous restricted list [10], reinforcing the idea that a transcrip-
tional cascade is the basic event in developmental programs
regulated by p63. RNA processing (39 genes) was found enriched,
confirming our previous classification and suggesting an important
role of p63 in global translational volume. New categories were
also significantly enriched: intracellular signaling cascade, in
particular IkappaBkinase/NF-kappaB cascade; regulation of cell cycle;
response to DNA damage stimulus; steroid hormone receptor activity and,
surprisingly, heart development. The gene ID of the GO categories
mentioned above are listed in Table S2.
Concerning NFkappaB, there are several studies implicating this
signaling pathway in development and homeostasis of the skin [14]
and of skin appendages [15]. Furthermore, IKKa is a transcrip-
tional target of p63 [16,17] and c-Rel can interact with p63 in
squamous carcinoma cells [18]. Cell cycle regulation was somewhat
expected, given the role of p63 in cancer biology [19–23] and
maintenance of ‘‘stemness’’ in epithelial biology [24,25]. In
particular the enrichment of the subcategory of regulation of caspase
activity (Figure S1) corroborates the role of p63 in the apoptotic
pathway [26,27] and confirms a recent finding linking p63 to
caspase8 and its regulator cFLIP [28].
Response to DNA damage stimulus was not totally unexpected, given
the similarity to p53; indeed, an elegant study highlighted the long
term function of TAp63 in the female germ line cells [27].
Figure 1. GO enrichment tree of p63 targets. Selected enriched GO categories and their respective number of genes with associated p values
are depicted in red. Scheme adapted from Figure S1.
doi:10.1371/journal.pone.0005008.g001
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RAR/RXR in skin biology or ER/AR on glandular development
is well documented [29,30]. We were somewhat surprised by the
paucity of adhesion/migration categories, since two expression
screenings indicated p63 at the center of specific adhesion
program [11] and metastatic invasion [12]. This may be due to
lack of adequate representation of these particular genes on our
arrays, or to a poor annotation of GO for such genes. Finally, since
there is only one piece of evidence of p63 expression in the heart
[31], it is hard to speculate on its role in this particular organ
development, but it may open new windows of investigation.
The transcription class was the most significantly enriched
(Figure 1) and we decided to deeply analyze this list of 179 genes
(Table S3). We selected 36 genes and tested them in three
functional assays for their ability to respond to p63: (i) p63 binding
in vivo in HaCaT cells, in promoter regions and other parts of their
locus, guided by an in silico analysis for putative p63/p53 binding
sites (see material and methods); (ii) endogenous expression after
silencing p63 in HaCaT; (iii) expression after DNp63a overex-
pression in 4 cell lines: U2OS, SAOS, HaCaT and adult primary
human keratinocytes (APHK). Finally, we monitored the presence
of each gene in available datasets generated after p63 silencing in
various epithelial cells [9,11,12,32–34]. We considered a gene
targeted by p63 if it fulfilled two of these three assays. The results
are summarized in Figure 2 (Raw data of all the experiments are
available upon request; see Figure S2 for controls). Only 5 genes
did not meet the set criteria (AFF3, ERC1, ERCC8, TBX5 and
TRPS1): therefore, we assumed that the list of 179 genes
represents p63 targets with a confidence of 86%.
We observed different scenarios in terms of expression changes:
increased expression in sip63 condition and decreased expression
in p63 overexpression -IRF1, IRF3, MTA2, NR4A2, PWP1,
SMAD7- or the reverse -ACTL6A, LEF1-, suggesting a direct
repression or activation, respectively. In other cases, the direction
of changes was the same for the two opposite conditions:
decreasing -NFYC, SNF8, SATB2, TLE6- or increasing -
JMJD2D, PPARD, TWIST1-, indicating that p63 may not be
the only factor influencing their transcription rate. Finally, the
variable extent of variation for some genes -CEBP/B, CHRAC1,
CLOCK, POLR3G, SALL4, TGFB1I1, ZNF256- and the
differential direction in the various lines suggest a key role for
the cellular context.
To evaluate the role of these targets in keratinocyte biology, we
monitored the expression of 26 genes in Q-PCR, at different time
points, during differentiation of HaCaT cells, adult and neonatal
primary keratinocytes (Figure 3). Expression changes of 24 genes
are observed; additional genes and differentiation controls are
shown in Figure S3. The general message is clear-cut: all p63
targets involved in transcriptional regulation vary during differen-
tiation, albeit to different extents and in different directions. In
particular, most increase in HaCaT and APHK, the exception
being CLOCK and JMJD2D in the former, PWP1, JMJD2D,
CHRAC1, SNF8 and REXO4 in the latter. In neonatal
keratinocytes, the patterns are much more complex: some genes
-TGFB1I1, SMAD7, PWP1, LEF1, SNF8, ACTL6A and
HOXC4- are dramatically decreased at later time points, while
others significantly increase -PPARD, SUPT3H, ID2, CITED2-
(Figure 3). This different behavior of neonatal versus adult primary
keratinocytes is quite striking and may reflect different skin
differentiation program in neonatal and adult life; it may depend
on the source of primary keratinocytes: foreskin versus breast, but
may also reflect the different differentiation conditions (see
materials and methods). Of note, DNp63 transcripts are also
expressed differently in response to differentiation stimuli in the
three systems (Figure 3). In summary, in keeping with the p63-led
control in human keratinocytes, the majority, and possibly all
transcriptional regulator targets vary in expression during
differentiation, suggesting a role in keratinocytes biology.
A network of Transcriptional targets
The dramatic phenotype observed in p63 null mice points to the
essential role of p63 in the initiation and maintenance of the
epithelia [7].
Using public available databases of interaction BIOGRID and
HPRD (http://www.thebiogrid.org/ and http://www.hprd.org/)
we built an ‘‘interactome’’ among the transcriptional regulators of
our list for which information was available (Figure 4). It is evident
that there are multiple interactors -TP53, PCAF, PML, RB1,
LEF1, CEBP/B-, and others with one partner. Notwithstanding
the obvious bias related to the enormous amount of information
gathered for some of them, there is evidence for a transcriptional
network sustaining the different programs in keratinocytes, with
many functional interactions contributing and helping p63 to
initiate these events.
Elegant studies in the muscle differentiation system identified a
handful of transcription factors (TF) -MRFs and MEF2- targeting
preferentially a large number of TFs, which, in turn, are
contributing to the differentiation process [35]. In the hemato-
poietic system, very complex cooperative and antagonistic
interplays between a considerable number of TFs, as well as
timing of their expression, regulate the different lineage specifica-
tions from the hematopoietic stem cells [36–38]. The epidermis
shares features with the above mentioned systems, namely the
necessity to produce terminally differentiated cells, but it also has
peculiarities. In fact, it is a continuously differentiating organ
which not only provides the main barrier of the body to the
external environment, but it also needs to respond in a quick way
to different types of external stimuli, ranging from chemical and
physical agents, to microbial attacks, to mechanical stresses and
wound healing. A complex relationships among these different
programs -self-renewal, differentiation, protection from DNA-
damage, immune response, and regeneration- is expected.
Therefore, the skin is at the same time simpler than the
hematopoietic system, in that essentially only one type of
terminally differentiated cell is produced, but still very complex,
for the need to deal with the exterior. We provide evidence that
the p63 transcriptional network is interconnected with several
nodes -or hubs- of single or small groups of transcriptional
regulators that are responsible for the different physiologic
function. Response to DNA damage is a task that p63 undertakes
personally, in conjunction with p53. The CEBPs are important in
a number of terminal differentiating systems [39]; E2Fs in
promoting cell-cycle progression [40,41]; NOTCH1 is coupling
growth and differentiation [42]; SMAD7 and LEF1 connect to
TGFb and WNT signaling [43]. PPARD is implicated in the
homeostasis of the permeability barrier of the skin [44]. Thus,
recruitment of different sets of transcriptional regulators by p63
might initiate specific response in the skin (Figure 5).
In summary, rather than a simple hierarchical ‘‘pyramid’’ with
p63 on top or a ‘‘master-slave’’ relationship, p63 can be viewed as
a connector. This scheme would provide a greater level of
plasticity required for the different tasks the epidermis is fulfilling
and we expect that the expression of p63 can be modulated by
many of these TFs: indeed, we have already started to dissect the
reciprocal interplay for one of the regulated TFs: CEBP/D [45].
Finally, we identified SALL4, one of the very upstream TF in
the specification of different blastocysts derived stem cell lineages
[46] and important in the stem cell network [47–49]. Further-
Skin Transcriptional Network
PLoS ONE | www.plosone.org 3 March 2009 | Volume 4 | Issue 3 | e5008Skin Transcriptional Network
PLoS ONE | www.plosone.org 4 March 2009 | Volume 4 | Issue 3 | e5008Figure 3. Expression of selected genes in differentiating HaCaT and PHK. Q-PCR analysis of the indicated genes in HaCaT (boxed in blue,
mean and SD of two different experiments), neonatal (boxed in green) and adult (boxed in red) human primary keratinocytes after CaCl2
differentiation. Time points of RNA collection are indicated on the bottom of the first chart in each row. Bars represent expression fold changes
respect to the 0 time point. Please, note the different scale on the y axes of each chart. Data were normalized for GAPDH expression and INVOLUCRIN
was chosen to monitor the differentiation status.
doi:10.1371/journal.pone.0005008.g003
Figure 2. Summary of the validating assays for the 36 transcriptional regulators targeted by p63. The results of the ChIPs on the
different selected genomic regions are indicated as positive (pos) when fold enrichment over flag was .2, weak positive (wp) when 1, fold
enrichment ,2 or negative (neg) if fold enrichment ,1. nt = not tested. Expression fold changes are indicated with an upward red arrow if the gene
was upregulated in the sip63 HaCaT sample or a downward green arrow if the gene was downregulated. The size of the arrow is indicative of the
amount of the fold change: thin for changes ,20% and thick for changes .20%. nc = no change. For the overexpression studies the same
representation is depicted with the addition of 2 different time points for the DNp63a overexpression in U2OS and the induction of SAOS; the small t
indicates a transient change of expression. For HaCaT and APHK only the DNp63a overexpression is considered. The + sign in the ChIP data column
indicates the presence of the gene in the binding data of [9]. The arrowheads in the other sip63 experiments column indicate expression changes in
the cited datasets: a [11], b [33], c [34], d [32], e [12] and f [9].
doi:10.1371/journal.pone.0005008.g002
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syndrome, also known as Okihiro syndrome, an autosomal
dominant disorder characterized by upper limb anomalies, ocular
anomalies, and, in some cases, renal anomalies [50,51]. Thus,
there is considerable overlap with syndromes caused by p63
mutations. The overlap is most pronounced in the limb
developmental defects, which likely originate in defective devel-
opment of the apical ectodermal ridge or maintenance of stem
cells of this specialized epithelium. For epithelial development of
the skin, SALL4 seems less important as skin defects are not a
notable feature of SALL4 mutations. Nevertheless, given the
importance of p63 in the stem cells of multilayered epithelia [24],
this connection is worth further investigation. Our future goal is to
dissect all these interactions, by focusing on the individual hubs of
the system, to understand the single contribution of each factor.
Materials and Methods
Analysis of binding data and location
The hybridization scheme of the immunoprecipitated material
on the 12K CpG island and the 12K promoter arrays was
described in [10]. For the CpG island array we considered positive
all the clones that satisfied the described criteria: .2 fold
enrichment in the a-p63 samples over the negative antibody -a-
flag- samples in each of the three performed experiments. For the
promoter arrays, we considered all the spots for which more than
Figure 4. An inner core of p63 transcriptional targets. Schematic representation of the documented interaction of the different p63
transcriptional targets.
doi:10.1371/journal.pone.0005008.g004
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fluorescence intensity of the background plus two standard
deviation and those showing enriched IP/control ratio .2 in all
four slides were considered positive.
The sequences of the positive CpG islands clones were retrieved
as described before [10]. Approximately 2 kb of genomic regions
both 59 and 39 of the CpG islands clones (or of the transcription
start sites for the positive promoter clones) were considered and
one or more gene ID were assigned to each clone, if they laid in
these regions. The genomic coordinates of the positive CpG
islands clones (based on the sequence information retrieved from
http://data.microarrays.ca/cpg/) and the 2800/+200 regions of
the positive promoter clones are supplied in Table S1
GO enrichment analysis was performed at http://bioinfo.
vanderbilt.edu/webgestalt with all the 1259 gene id retrieved, but
only 1159 were recognized as such. The default settings used were
the WebGestalt_Human reference gene set and the Hypergeo-
metric statistical test.
The interaction databases BIOGRID and HPRD can be found
at these addresses http://www.thebiogrid.org/ and http://www.
hprd.org/
Analysis of p63/p53 binding site
In order to predict the position of p63 binding sites we used
PWM descriptors [52] of p63 and p53 binding preferences. For
p63 we used the matrix reported in [53], while for p53 we
employed the one found in Jaspar database [54]. Those two
profiles were used to score every oligonucleotide (of the same
length of the profile) composing the analysed sequences according
to the method described in [55]. Oligonucleotides scoring more
than 0.80 with at least one of the two matrices were chosen for
further investigation. Oligonucleotides scoring more than 0.85
with at least one of the two half site versions of the profiles were
also considered.
Analysis of sip63 microarray data
HaCaT [12] and MCF10A [11]. The data were provided by
the authors as average of the control (Ctrl) class linear signal and
average of the p63 RNA interference (p63si) class linear signal.
The Affymetrix probe-sets were ranked according to log2 (p63si/
Ctrl), weighted by the log10 (expression signal) in the two classes;
probe-sets with a signal smaller than an arbitrary thresholds in Ctrl
or p63 were removed from the list of the down-regulated and up-
regulated, respectively; the filtering and the weighting were
introduced to avoid the selection of probe-sets with small
absolute variation but large ratio. Down-regulated (high in Ctrl)
and Up-regulated (high in p63si) were selected applying a
symmetric threshold. A very similar ratio between up-regulated
and down-regulated was obtained even without filtering and
weighting, but simply using the log2(ratio).
Mouse primary keratinocytes [33]. The data were
provided by the authors as raw .CEL files. The data were
imported from .CEL files using the Affy package (R/
Bioconductor), and the rma statistic was generated for the
probe-sets using the rma package (R/Bioconductor). The genes
were ranked according to an empirically corrected signal-to-noise:
mean.siRNA - mean.Ctrl)/(sd.siRNA+sd.Ctrl+constant). The
FDR was estimated as the ratio between the number of probe-
Figure 5. Link of p63 with transcriptional targets. Schematic representation of the recruitment and interplay of p63 and some of its
transcriptional targets to direct specific function of the skin.
doi:10.1371/journal.pone.0005008.g005
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signal-to-noise; the random signal-to-noise was calculated after the
independent random permutation of all the expression matrix
rows. The random permutation of the expression matrix columns
could not be used due to the limited number of the control class
replicates (only two). The constant in the signal-to-noise formula
was set to 1, after a few assessments of observed positives and FDR
with different values of the constant. The lists of down-regulated
probe-sets were generated for 12.2% and 7.6% estimated FDR.
HaCaT [34]. Only one replicate was available for each class.
Therefore we used the Sscore package (R/Bioconductor) to
generate differentiality statistics [56]. The data were imported
from .CEL files using the Affy package (R/Bioconductor). The p-
values were calculated under the normality assumption for the
Sscore distribution, as recommended by the authors. The raw p-
values were then corrected using the Benjamini-Hochberg method.
For ME180 [9] and human primary keratinocytes [32]
the lists were used as supplied by the authors.
Chromatin Immunoprecipitation. The procedure for ChIP
was essentially as described previously [10] using 3–5610
6 HaCaT
cells per 10–15 mg antibody. Two specific a-p63 antibodies were
used: a rabbit polyclonal generated in our lab [10] and the mouse
monoclonal 4A4 (Santa Cruz), and the negative control one was the
a-flag (Sigma). The immunoprecipitated DNA was analyzed with
region specific primers both in semi quantitative standard PCR
assays and in Q-PCR.
Cell culture, transfection, in vitro differentiation and RNA
extraction. HaCaT, SAOS and U2OS cells were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10%
foetal calf serum, 100 IU penicillin and 100 mg streptomycin per
ml. First passage primary adult human keratinocytes (APHK) were
derived from healthy individuals and grown on a feeder-layer of
lethally irradiated 3T3 cells [10]. Neonatal primary human
keratinocytes (NPHK) were purchased from CELLnTEC (Bern,
Switzerland) and maintained for 4–5 passages in Progenitor Cell
targeted Culture Media (CnT-57, CELLnTEC).
For in vitro differentiation assays, HaCaT cells were grown in
0.1% FCS and CaCl2 was added to a final concentration of
1.4 mM. Cells were harvested at 0, 3 and 72 hours after calcium
induction. APHK were seeded on Mitomycin C (Sigma) arrested
3T3 cells and CaCl2 concentration was increased to 1.4 mM. Cells
were harvested at 0, 28 and 72 hours after calcium induction.
Subconfluent NPHK at passage 5 or 6 were switched to CnT-02
differentiation medium (CELLnTEC, Bern, Switzerland) and 1
day later 1.2 mM CaCl2 was added. Cells were harvested at
different time points up to 11 days post calcium addition.
Transfections were carried out with Lipofectamine 2000
(Invitrogen, Milan, Italy). 5 mgo fDNp63a were used for a
100 mm plate of U2OS. 24 mg of TAp63a, DNp63a, b and c
were used for 100 mm plates of HaCaT or APHK cells. The p63
expression plasmids were described previously [10]. Induction of
SAOS cells (kindly provided by E. Candi) was done with 2 mg/ml
of Doxycycline (Sigma-Aldrich, Italy). Cells were collected after
24 h (U2OS, SAOS, HaCaT and APHK) and 48 hours (U2OS
and SAOS) post transfection/induction. RNA was extracted with
the RNAeasy kit (Qiagen, Milan, Italy) or TriReagent (Sigma-
Aldrich, Italy) according to manufacturer’s instructions.
For siRNA experiments, 4610
6 HaCaT cells were seeded onto
100 mm plates, allowed to attach to the substratum and
transfeceted using Lipofectamine 2000 with 60nM siRNA
scramble (Ambion/Applied Biosystems, Austin, Texas, USA) or
si directed against the DNA binding domain of p63 [34]. After an
overnight incubation, a second transfection was performed and
cells were collected 48 h later.
1o r2mg of RNAs were reverse-transcribed using Superscript II
(Invitrogen) and cDNAs were normalized to GAPDH levels.
Q-PCR analysis of ChIP and RT. A Biorad MyIQ single
colour thermal cycler and a SYBR Green PCR Master mix was
used in all Q-PCR experiments. Specificity of products was
monitored with a heat dissociation curve. For ChIP, fold
enrichment was calculated with the formula 2
2DDCt where the
Ct represented the threshold cycles of the input, the specific
antibody and the negative antibody; a further normalization with
the enrichment obtained on a negative genomic region
(centromeric satellite 11) was applied. For RT-PCR, fold
changes of expression were calculated with the formula 2
2DDCt
where the Ct represented the threshold cycles of the specific gene
and GAPDH. The 0 time point was always taken as the reference
point in each set of experiments and the si scramble point was the
reference in the si experiment. A list of the ChIP and RT primers
used is provided in Table S4.
Supporting Information
Figure S1 GO tree from Webgestalt
Found at: doi:10.1371/journal.pone.0005008.s001 (2.07 MB EPS)
Figure S2 Controls of p63 silencing and overexpression.
Western Blot with a-p63 antibody on total extracts of silenced
HaCaT (top), transfected U2OS, HaCaT and APHK, and
induced SAOS cells, to detect levels of p63 reduction or different
p63 isoforms overexpression. In the silencing experiments, a-
vinculin was used as a loading control.
Found at: doi:10.1371/journal.pone.0005008.s002 (1.27 MB EPS)
Figure S3 Expression analysis of selected genes in differentiating
keratinocytes. Standard RT PCR analysis of two additional targets
in differentiating NPHK and differentiation control expression of
Filaggrin and Keratin5 in APHK. GAPDH was used to normalize
the cDNAs
Found at: doi:10.1371/journal.pone.0005008.s003 (1.03 MB EPS)
Table S1 Extended list of p63 targets: 1259 gene id and genomic
coordinates. The back rows are genes coming from the CpG island
array, while the blue ones are from the promoter array. The genes
in common between the two platforms are in red. The annotation
in the ChIP column is the same as in Table I. s are data from [1].
The letters in the column other sip63 experiments are the same as
in Table I. The other worksheet lists the genomic coordinates of
the positive clones from both CpG and promoter arrays. They can
be uploaded on the UCSC genome browser (human, March 2006
assembly) 1. Birkaya B, Ortt K, Sinha S (2007) Novel in vivo
targets of DeltaNp63 in keratinocytes identified by a modified
chromatin immunoprecipitation approach. BMC Mol Biol 8: 43
Found at: doi:10.1371/journal.pone.0005008.s004 (0.24 MB
XLS)
Table S2 Gene ID in the different GO categories
Found at: doi:10.1371/journal.pone.0005008.s005 (0.03 MB
XLS)
Table S3 179 enriched trascriptional target from the Webgestalt
classification. Additional references cited in this table: [2–7] 2. Lo
Iacono M, Di Costanzo A, Calogero RA, Mansueto G, Saviozzi S,
et al. (2006) The Hay Wells syndrome-derived TAp63al-
phaQ540L mutant has impaired transcriptional and cell growth
regulatory activity. Cell Cycle 5: 78–87. 3. Trink B, Osada M,
Ratovitski E, Sidransky D (2007) p63 transcriptional regulation of
epithelial integrity and cancer. Cell Cycle 6: 240–245. 4.
Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA, et
al. (2006) p63 regulates multiple signalling pathways required for
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1553–1563. 5. Bernassola F, Oberst A, Melino G, Pandolfi PP
(2005) The promyelocytic leukaemia protein tumour suppressor
functions as a transcriptional regulator of p63. Oncogene 24:
6982–6986. 6. Ortt K, Raveh E, Gat U, Sinha S (2008) A
chromatin immunoprecipitation screen in mouse keratinocytes
reveals Runx1 as a direct transcriptional target of DeltaNp63. J
Cell Biochem 104: 1204–1219. 7. Guttormsen J, Koster MI,
Stevens JR, Roop DR, Williams T, et al. (2008) Disruption of
epidermal specific gene expression and delayed skin development
in AP-2 gamma mutant mice. Dev Biol 317: 187–195.
Found at: doi:10.1371/journal.pone.0005008.s006 (0.04 MB
XLS)
Table S4 List of primers used in ChIP and RT-PCR
experiments.
Found at: doi:10.1371/journal.pone.0005008.s007 (0.03 MB
XLS)
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